News Releases

2011
2010
2009
2008
2007
2006
2005
2004

 

November16, 2009 Protox Reports 2009 Third Quarter Results

 

October 29, 2009 Protox Presents Phase 2 BPH Data at the World Congress of the Societe Internationale D’Urologie

 

September 10, 2009 Protox Announces Positive 12 Month Phase 2 BPH Results

 

September 9, 2009 Protox to present at the 11th Annual Rodman & Renshaw Healthcare Conference

 

September 8, 2009 Protox Completes Enrollment of Phase 2B BPH Trial

 

August 14, 2009 Protox Reports 2009 Second Quarter Results
  June 29, 2009 Protox to Present Benign Prostatic Hyperplasia Data at Canadian Urology Conference
  June 16, 2009 Protox Appoints Dr. Alexander Giaquinto to Board of Directors
  May 20, 2009 Protox completes $2.31 million private placement
  May 15, 2009 Protox reports 2009 first quarter results
  April 29, 2009 Protox Presents BPH Data at the Annual American Urological Association Conference
  April 28, 2009 Protox Announces Private Placement
  March 26, 2009 Protox Reports 2008 Financial Results and Achievements
  March 23, 2009 Protox Appoints Chief Financial Officer
  January 12, 2009 Protox Announces Initiation of Placebo Controlled Phase 2 BPH Study

What's New

December 28, 2011
Protox Therapeutics Announces Closing of Additional CDN $8.3M Investment By Warburg Pincus

December 23, 2011
Protox Therapeutics Announces Additional CDN $8.3M Investment by Warburg Pincus

December 22, 2011
Protox Completes Dosing of Second Cohort of Patients in Transrectal Study

 

 

 

Events

November 17, 2010
- 11:15 am ET
Protox Presents at Dundee Emerging Growth Conference

 

Stock Quote

LAST TRADE:$0.35
TRADE TIME:3:49PM EST
CHANGE:$0.02 (6.06%)
PREV CLOSE: $0.33
OPEN:$0.335
BID:$0.34
ASK:$0.35